Olanzapine for vomiting in children after chemotherapy
Treatments studied
Part of Cancer clinical trials.
This trial tests whether the drug olanzapine can reduce breakthrough vomiting in children who still vomit despite standard preventive medicines. It aims to improve comfort during cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 5 to 18 years
- Current cancer diagnosis and receiving chemotherapy
- Currently taking preventive anti-nausea medicines (like ondansetron, aprepitant, dexamethasone)
- Still have vomiting despite these medicines
- Weigh at least 10 kg (about 22 pounds)
- Be well enough to carry out daily activities (performance score above 50 or ECOG less than 3)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new, easy-to-take film that melts on the tongue to prevent vomiting caused by radiation therapy in children with cancer. It may be a good option if your child is getting radiation to the belly or spine and has trouble swallowing pills.
This trial compares two anti-nausea drug regimens (one with olanzapine, one with dexamethasone) to prevent delayed nausea and vomiting after a stem cell transplant for multiple myeloma. It aims to find which is better at controlling these side effects.
This study tests if the drug olanzapine (commonly used for nausea) can help prevent vomiting in people receiving moderately strong chemotherapy for the first time. It may be a good fit if you're about to start treatment with oxaliplatin, irinotecan, or carboplatin and haven't had severe nausea treatments before.
This trial tests whether the drug olanzapine can help reduce side effects of chemotherapy when given before surgery for stomach cancer, potentially helping patients feel better and complete their treatment.
This study tests whether olanzapine, a medication that can increase appetite, helps prevent severe appetite loss and muscle wasting in patients with ovarian or stomach cancer who are receiving chemotherapy before surgery. The goal is to help patients maintain nutrition and strength during treatment.
This trial tests if the drug olanzapine can help improve appetite in people with head and neck cancer who are getting chemotherapy and radiation. It aims to prevent or reduce weight loss during treatment.
Hear when a new Pediatric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.